scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.28), $0.09 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.68 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.